Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Vianet Group (VNET) by Steve Moore in ShareProphets
- Buy Jet2 (JET2) by Canaccord Genuity
- Buy System1 Group (SYS1) by Canaccord Genuity
- Avoid Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Outperform Barratt Redrow (BTRW) by RBC Capital
- Buy The Gym Group (GYM) by Shore Capital
- Buy Next 15 Group (NFG) by Berenberg
- Buy Unite Group (UTG) by Berenberg
- Buy Victoria (VCP) by Berenberg
- Avoid EnSilica (ENSI) by Steve Moore in ShareProphets
- Hold BP (BP.) by Mark Hartley in The Motley Fool
- Overweight Hochschild Mining (HOC) by Barclays
- Hold Keller Group (KLR) by Deutsche Bank
- Hold Hilton Food Group (HFG) by Kepler Cheuvreux
- Equal Weight BP (BP.) by Barclays
- Overweight Glencore (GLEN) by Barclays
- Overweight Anglo American (AAL) by Barclays
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Citi
- Overweight International Consolidated Airlines Group SA (CDI) (IAG) by Barclays
- Overweight easyJet (EZJ) by Barclays
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,276 open tips for AstraZeneca (AZN)
| Latest Bid : 14,204.00p | Latest Ask : 14,208.00p |
| High Today : 14,332.00p | Low Today : 14,086.00p |
| This Years High : 15,316.00p | This Years Low : 10,232.00p |
| Volume : 781,890 | MKT Cap : £220720M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | HSBC | Premium Only | 2026-07-07 09:33:00 07/07/2026 | 0.51% |
| Buy | HSBC | Premium Only | 2026-07-06 09:43:00 06/07/2026 | -1.45% |
| Outperform | Bernstein | Premium Only | 2026-07-06 09:43:00 06/07/2026 | -1.45% |
| Buy | Goldman Sachs | Premium Only | 2026-07-01 09:41:00 01/07/2026 | 0.25% |
| Buy | Jefferies | Premium Only | 2026-06-26 15:30:00 26/06/2026 | -0.38% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 14,204.00p | Latest Ask : 14,208.00p |
| High Today : 14,332.00p | Low Today : 14,086.00p |
| This Years High : 15,316.00p | This Years Low : 10,232.00p |
| Volume : 781,890 | MKT Cap : £220720M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | HSBC | Premium Only | 2026-07-07 09:33:00 07/07/2026 | 0.51% |
| Buy | HSBC | Premium Only | 2026-07-06 09:43:00 06/07/2026 | -1.45% |
| Outperform | Bernstein | Premium Only | 2026-07-06 09:43:00 06/07/2026 | -1.45% |
| Buy | Goldman Sachs | Premium Only | 2026-07-01 09:41:00 01/07/2026 | 0.25% |
| Buy | Jefferies | Premium Only | 2026-06-26 15:30:00 26/06/2026 | -0.38% |